Vitamin K antagonists
Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review
... and vitamin K antagonists (VKA) in the long treatment of venous thromboembo- lism, but in populations not restricted to patients with cancer [7-9] The review by van der Heijden et ...
11
Incidence of left atrial abnormalities under treatment with dabigatran, rivaroxaban, and vitamin K antagonists
... Non-vitamin K antagonist oral anticoagulants (NOACs) such as dabigatran or rivaroxaban are alterna- tives to vitamin K antagonists (VKAs) for prevention of stroke and systemic embolism ...
9
Bench to bedside review: Optimising emergency reversal of vitamin K antagonists in severe haemorrhage – from theory to practice
... K antagonists have an international normalised ratio (INR) higher than the target of ...with vitamin K antagonists per year ...receiving vitamin K antagonists ...
10
Estimation of the cost-effectiveness of apixaban versus vitamin K antagonists in the management of atrial fibrillation in Argentina
... oral vitamin K antagonists (VKAs), warfarin and acenocoumarol, and, in patients who were unsuitable for these drugs, aspirin, alone or in association with ...
10
Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis
... Background: Patients with cancer are at increased risk of venous thromboembolism (VTE) and the risk is further elevated after a primary VTE. To reduce the risk of recurrent events, extended prophylaxis with ...
9
Making safer preoperative arrangements for patients using vitamin K antagonists
... After exploration of barriers, multiple interventions were carried out to encourage co-workers at the preoperative screening department to take shared responsibility: distribution of prints, adjustments in electronic ...
7
FACTORS INVOLVED IN THE IMBALANCE OF VITAMIN K ANTAGONISTS: EVALUATION OF PATIENTS' KNOWLEDGE AND PRACTICES
... purpose: Vitamin K antagonists (VKA) are considered to be one of the top five medications that are directly related to drug errors and to be one of the most common causes of emergency ...
19
New oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic events
... anticoagulant vitamin K antagonist (VKA) drugs, the prevention and treatment of venous and arterial thrombotic phenomena remain major medical ...non-vitamin K antagonist oral anticoagulants ...
11
Effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists for people aged 75 years and over with atrial fibrillation : a systematic review and meta-analysis of observational studies
... a vitamin K antagonist [13–31,33,34] (n = 21); rivaroxaban [14,16–21,25,27,28,31] and apixaban [14,17,19–21,31,32] were licensed later so have not been studied as extensively (n = 11 and n = 7, ...
21
Bridging anticoagulation in patients treated with vitamin K antagonists prior to trochanteric and hip fracture surgeries: The current practice
... ACEI – angiotensin-converting-enzyme inhibitors; AF – atrial fibrillation; APTT – activated partial thromboplastin time; ASA – acetylsalicylic acid; ARB – angiotensin receptor blockers; BMI – body mass index; CHD – ...
9
Use of vitamin K antagonists for secondary stroke prevention depends on the treating healthcare provider in Germany – results from the German AFNET registry
... The strengths of our analysis include the large sample size of almost 10,000 registry patients with AF, the ability to discriminate between medical stroke prevention before and after enrolment to the AFNET registry, the ...
8
Non-vitamin K antagonist oral anticoagulants vs. vitamin-K antagonists in patients with atrial fibrillation and chronic kidney disease: a nationwide cohort study
... Danish study found that AF patients with non-end-stage CKD or end-stage CKD had an increased risk of stroke/ TE of 50 and 83%, respectively, compared to patients without renal disease [2]. Furthermore, the presence of ...
8
Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance
... • One part related to bleeding signs and management of bleeding or nonbleeding patients with a high INR: For all patients, signs of hemorrhage and internal bleeding were indicated, such as epistaxis, gastrointestinal ...
8
Four-factor prothrombin complex concentrates: effectiveness in the reversal of anticoagulation
... Abstract: Vitamin K antagonists (VKAs) continue to be the most commonly prescribed class of oral anticoagulants worldwide for the treatment and prevention of venous or arterial thromboembolic events ...
9
Dabigatran in the Treatment of Extensive Cerebral Venous Thrombosis: A Case Report
... infarction. Vitamin K antagonists have long been the only available option for anticoagulation; however, the past few years have brought the development of many new target-specific drugs, ...
6
Vitamin K and stability of oral anticoagulant therapy
... We found several patient and treatment characteristics that were associated with the risk of underanticoagulation. A possible explanation for the difference in frequency of occurrence of subtherapeutic anticoagulation ...
111
<p>Reliability and validity of the Maltese version of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q)</p>
... instance, vitamin K antagonists (VKA), such as warfarin, have several food and drug interactions and require dose adjustment, therefore mandating periodic blood testing of the international ...
11
Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary artery stenting: hovering among bleeding risk, thromboembolic events, and stent thrombosis
... AF: Atrial fibrillation; OAC: Oral anticoagulation; VKA: Vitamin K antagonists; DAPT: Dual anti-platelet treatment; TT: Triple antithrombotic therapy; PCI- S: Percutaneous coronary inter[r] ...
11
A review of Warfarin woes and non Vitamin k dependent anticoagulants benefits
... of vitamin K. Vitamin K antagonists, also known as oralanticoagulants (OACs), are widely used for the treatment and prophylaxis of thromboebolic ...indicated; Vitamin K is ...
6
Clinical Reasoning: An 87-year-old woman with left-sided numbness
... non-vitamin K oral anticoagulants (NOACs) are as effective as vitamin K antagonists (VKAs) such as warfarin in the prevention of stroke and systemic embolism in patients with AF with a ...
7